Shares of athenahealth, Inc. (NASDAQ:ATHN) have earned a consensus recommendation of “Hold” from the twenty-eight research firms that are presently covering the company, MarketBeat.com reports. Two analysts have rated the stock with a sell rating, fourteen have given a hold rating and eleven have assigned a buy rating to the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $143.00.

Several analysts recently issued reports on ATHN shares. TheStreet raised shares of athenahealth from a “c” rating to a “b-” rating in a report on Thursday, July 20th. SunTrust Banks, Inc. reaffirmed a “buy” rating and issued a $150.00 price target on shares of athenahealth in a report on Monday, July 17th. Piper Jaffray Companies reaffirmed a “buy” rating and issued a $152.00 price target on shares of athenahealth in a report on Friday, July 14th. Citigroup Inc. reissued a “buy” rating and set a $169.00 target price (up from $163.00) on shares of athenahealth in a report on Monday, July 10th. Finally, Robert W. Baird reissued a “buy” rating and set a $170.00 target price on shares of athenahealth in a report on Thursday, August 31st.

In other news, Director Brandon H. Hull sold 800 shares of the firm’s stock in a transaction dated Friday, September 1st. The shares were sold at an average price of $140.95, for a total transaction of $112,760.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Jonathan D. Porter sold 300 shares of the firm’s stock in a transaction dated Tuesday, August 15th. The shares were sold at an average price of $142.88, for a total transaction of $42,864.00. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 12,783 shares of company stock valued at $1,680,236. Insiders own 3.20% of the company’s stock.

Several large investors have recently bought and sold shares of ATHN. Russell Investments Group Ltd. lifted its stake in athenahealth by 380.8% during the first quarter. Russell Investments Group Ltd. now owns 5,409 shares of the health services provider’s stock valued at $609,000 after buying an additional 4,284 shares in the last quarter. UBS Asset Management Americas Inc. lifted its stake in athenahealth by 14.0% during the first quarter. UBS Asset Management Americas Inc. now owns 22,931 shares of the health services provider’s stock valued at $2,584,000 after buying an additional 2,820 shares in the last quarter. Legal & General Group Plc lifted its stake in athenahealth by 193.4% during the first quarter. Legal & General Group Plc now owns 12,914 shares of the health services provider’s stock valued at $1,455,000 after buying an additional 8,513 shares in the last quarter. Dimensional Fund Advisors LP lifted its stake in athenahealth by 37.3% during the first quarter. Dimensional Fund Advisors LP now owns 121,650 shares of the health services provider’s stock valued at $13,708,000 after buying an additional 33,061 shares in the last quarter. Finally, UBS Group AG lifted its stake in athenahealth by 145.5% during the first quarter. UBS Group AG now owns 8,794 shares of the health services provider’s stock valued at $991,000 after buying an additional 28,115 shares in the last quarter.

athenahealth (NASDAQ:ATHN) last announced its earnings results on Thursday, October 19th. The health services provider reported $0.56 earnings per share for the quarter, beating the consensus estimate of $0.50 by $0.06. The business had revenue of $304.60 million during the quarter, compared to the consensus estimate of $310.52 million. athenahealth had a net margin of 2.65% and a return on equity of 6.78%. The business’s quarterly revenue was up 10.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.60 earnings per share.

TRADEMARK VIOLATION WARNING: This news story was posted by American Banking News and is the sole property of of American Banking News. If you are viewing this news story on another site, it was copied illegally and republished in violation of US and international trademark & copyright law. The original version of this news story can be viewed at https://www.americanbankingnews.com/2017/11/02/athenahealth-inc-athn-given-consensus-rating-of-hold-by-analysts.html.

athenahealth Company Profile

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Analyst Recommendations for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related companies with MarketBeat.com's FREE daily email newsletter.